| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,911 |
8,814 |
$336K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,916 |
2,892 |
$235K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,377 |
2,290 |
$202K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,605 |
2,537 |
$196K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,571 |
1,549 |
$119K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,316 |
2,157 |
$109K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,636 |
4,190 |
$71K |
| 99381 |
|
594 |
590 |
$48K |
| 99429 |
|
950 |
923 |
$28K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,149 |
1,120 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,302 |
2,480 |
$26K |
| 99000 |
|
2,689 |
2,316 |
$25K |
| 90461 |
|
2,325 |
1,809 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
541 |
496 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
379 |
365 |
$15K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,672 |
824 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
892 |
873 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,278 |
1,225 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
474 |
465 |
$7K |
| 96160 |
|
2,479 |
2,359 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
71 |
71 |
$4K |
| 99383 |
|
40 |
40 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
41 |
41 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
435 |
398 |
$3K |
| 99051 |
|
328 |
317 |
$3K |
| 0001A |
|
86 |
74 |
$3K |
| 0002A |
|
56 |
56 |
$2K |
| 94010 |
|
60 |
60 |
$2K |
| 90474 |
|
189 |
186 |
$1K |
| 81002 |
|
520 |
420 |
$1K |
| 97169 |
|
29 |
29 |
$785.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
46 |
46 |
$701.27 |
| A4617 |
Mouth piece |
64 |
64 |
$213.46 |
| 90620 |
|
471 |
439 |
$67.34 |
| A7015 |
Aerosol mask, used with dme nebulizer |
45 |
45 |
$65.64 |
| 90696 |
|
285 |
280 |
$52.50 |
| 90734 |
|
893 |
844 |
$27.92 |
| 96161 |
|
114 |
113 |
$11.12 |
| 90648 |
|
1,131 |
1,120 |
$5.78 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
43 |
43 |
$1.75 |
| 36416 |
|
1,049 |
1,027 |
$1.62 |
| 90670 |
|
1,392 |
1,375 |
$0.00 |
| 90633 |
|
634 |
625 |
$0.00 |
| 90700 |
|
136 |
136 |
$0.00 |
| 91300 |
|
144 |
130 |
$0.00 |
| 90707 |
|
132 |
132 |
$0.00 |
| 90715 |
|
422 |
405 |
$0.00 |
| 90710 |
|
301 |
296 |
$0.00 |
| 90723 |
|
995 |
984 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
7,301 |
7,076 |
$0.00 |
| 90651 |
|
990 |
951 |
$0.00 |
| 90686 |
|
1,921 |
1,874 |
$0.00 |
| 90680 |
|
955 |
943 |
$0.00 |
| 90647 |
|
59 |
58 |
$0.00 |
| 90716 |
|
136 |
136 |
$0.00 |
| 91307 |
|
33 |
32 |
$0.00 |